表皮生长因子受体

Epidermal growth factor receptor; 表皮生长因子受体
	表皮生长因子受体的胞外结构域与表皮生长因子结合的复合体，引自PDB1nql[1]
有效结构
PDB	直系同源检索：PDBe, RCSB
PDB查询代码列表
	1IVO, 1M14, 1M17, 1MOX, 1NQL, 1XKK, 1YY9, 1Z9I, 2EB2, 2EB3, 2GS2, 2GS7, 2ITN, 2ITO, 2ITP, 2ITQ, 2ITT, 2ITU, 2ITV, 2ITW, 2ITX, 2ITY, 2ITZ, 2J5E, 2J5F, 2J6M, 2JIT, 2JIU, 2JIV, 2KS1, 2M0B, 2M20, 2RF9, 2RFD, 2RFE, 2RGP, 3B2U, 3B2V, 3BEL, 3BUO, 3C09, 3G5V, 3G5Y, 3GOP, 3GT8, 3IKA, 3LZB, 3NJP, 3OB2, 3OP0, 3P0Y, 3PFV, 3POZ, 3QWQ, 3UG1, 3UG2, 3VJN, 3VJO, 3VRP, 3VRR, 3W2O, 3W2P, 3W2Q, 3W2R, 3W2S, 3W32, 3W33, 4G5J, 4G5P, 4HJO, 4I1Z, 4I20, 4I21, 4I22, 4I23, 4I24, 4JQ7, 4JQ8, 4JR3, 4JRV, 4KRL, 4KRM, 4KRO, 4KRP, 4LI5, 4LL0
标识
代号	EGFR; ERBB; ERBB1; HER1; PIG61; mENA
扩展标识	遗传学：131550 鼠基因：95294 同源基因：74545 ChEMBL: 203 GeneCards: EGFR Gene
EC編號	2.7.10.1
基因本体论描述
分子功能	· double-stranded DNA binding; · MAP kinase kinase kinase activity; · protein tyrosine kinase activity; · transmembrane receptor protein tyrosine kinase activity; · receptor signaling protein tyrosine kinase activity; · transmembrane signaling receptor activity; · epidermal growth factor-activated receptor activity; · protein binding; · ATP binding; · enzyme binding; · protein phosphatase binding; · nitric-oxide synthase regulator activity; · identical protein binding; · protein heterodimerization activity; · actin filament binding;
细胞成分	· Golgi membrane; · extracellular space; · nucleus; · cytoplasm; · endosome; · endoplasmic reticulum membrane; · plasma membrane; · endosome membrane; · membrane; · integral to membrane; · basolateral plasma membrane; · AP-2 adaptor complex; · nuclear membrane; · membrane raft; · perinuclear region of cytoplasm; · Shc-EGFR complex;
生物过程	· MAPK cascade; · activation of MAPKK activity; · ossification; · embryonic placenta development; · hair follicle development; · response to stress; · signal transduction; · cell surface receptor signaling pathway; · epidermal growth factor receptor signaling pathway; · activation of phospholipase C activity; · axon guidance; · salivary gland morphogenesis; · cell proliferation; · positive regulation of cell proliferation; · fibroblast growth factor receptor signaling pathway; · cell-cell adhesion; · cerebral cortex cell migration; · positive regulation of cell migration; · positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S; · positive regulation of catenin import into nucleus; · negative regulation of epidermal growth factor receptor signaling pathway; · negative regulation of protein catabolic process; · positive regulation of phosphorylation; · activation of phospholipase A2 activity by calcium-mediated signaling; · negative regulation of apoptotic process; · positive regulation of MAP kinase activity; · innate immune response; · positive regulation of nitric oxide biosynthetic process; · positive regulation of DNA repair; · positive regulation of DNA replication; · protein autophosphorylation; · neurotrophin TRK receptor signaling pathway; · phosphatidylinositol-mediated signaling; · positive regulation of fibroblast proliferation; · digestive tract morphogenesis; · positive regulation of epithelial cell proliferation; · regulation of peptidyl-tyrosine phosphorylation; · regulation of nitric-oxide synthase activity; · protein insertion into membrane; · positive regulation of protein kinase B signaling cascade; · morphogenesis of an epithelial fold; · response to UV-A;
	Sources: Amigo / QuickGO
RNA表达模式
	更多表达数据
直系同源体

表皮生长因子受体（英語：，简称为EGFR、ErbB-1或HER1）是一类名为表皮生长因子家族（EGF-家族）的细胞外蛋白配体的细胞表面受体[2] 。

表皮生长因子受体是ErbB受体家族家族的成员之一，ErbB家族是包含四种紧密联系蛋白的亚家族，这四种蛋白分别是受体酪氨酸激酶类：EGFR（ErbB-1）、HER2/c-neu（ErbB-2）、Her 3（ErbB-3）以及Her 4（ErbB-4）。影响EGFR表达或活性的突变可能导致癌症[3]。

表皮生长因子及其受体是由范德堡大学的斯坦利·科恩发现的，科恩与丽塔·列维-蒙塔尔奇尼因发现生长因子类而共同获得了1986年诺贝尔生理学或医学奖。

功能

EGFR信号传导级联

表皮生长因子受体（EGFR）存在于细胞表面且因结合特异性受体而被激活，这些受体包括表皮生长因子和转化生长因子-α。ErbB2并无已知的直接激活配体，可能结构性地处于激活状态，或在与如EGFR等其他家族成员形成异源二聚体时被激活。除了參與正常的生理功能之外，EGFR在癌症中同樣扮演了重要的角色，以非小細胞性肺癌(NSCLC)為例，在全球患有非小細胞性肺癌的病患中，高達20%都表現了EGFR基因的突變，所以目前的藥物多朝向EGFR tyrosine kinase inhibitor去做設計，以期達到治療的效果。 [4] 目前發現具有EGFR突變型的NSCLC癌細胞會對tyrosine kinase inhibitor產生抗藥作用，這個抗藥作用可能來自於其中細胞大量的endothelin表現，進而使腫瘤組織血管收縮，降低了抗癌藥物的灌流，產生類似抗藥性的效果。 [5]

参考文献

Kathryn M. Ferguson, Mitchell B. Berger, Jeannine M. Mendrola, Hyun Soo Cho, Daniel J. Leahy, Mark A. Lemmon. . Molecular Cell. 2003-02, 11 (2): 507–517 [2019-05-26]. ISSN 1097-2765. PMID 12620237.
Herbst RS. . Int. J. Radiat. Oncol. Biol. Phys. 2004, 59 (2 Suppl): 21–6. PMID 15142631. doi:10.1016/j.ijrobp.2003.11.041.
Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI. . J. Clin. Invest. August 2007, 117 (8): 2051–8. PMC 1934579. PMID 17671639. doi:10.1172/JCI32278.
Yuhong Lu , Yanfeng Liu , Sebastian Oeck , Gary J. Zhang , Alexander Schramm , and Peter M. Glazer. . Cancer Res. November 1 2020, 80 (21): 4655-4667. doi:10.1158/0008-5472.CAN-20-1192. 请检查|date=中的日期值 (帮助)
A.A. Armour, C.L. Watkins. . Cancer Res. October 1 2020, 80 (19): 4023-4024. doi:10.1158/0008-5472.CAN-20-0141. 请检查|date=中的日期值 (帮助)

深入阅读

Carpenter G. . Annu. Rev. Biochem. 1987, 56 (1): 881–914. PMID 3039909. doi:10.1146/annurev.bi.56.070187.004313.
Boonstra J, Rijken P, Humbel B; 等. . Cell Biol. Int. 1995, 19 (5): 413–30. PMID 7640657. doi:10.1006/cbir.1995.1086.
Carpenter G. . BioEssays. 2000, 22 (8): 697–707. PMID 10918300. doi:10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.0.CO;2-1.
Filardo EJ. . J. Steroid Biochem. Mol. Biol. 2002, 80 (2): 231–8. PMID 11897506. doi:10.1016/S0960-0760(01)00190-X.
Tiganis T. . IUBMB Life. 2002, 53 (1): 3–14. PMID 12018405. doi:10.1080/15216540210811.
Di Fiore PP, Scita G. . Int. J. Biochem. Cell Biol. 2002, 34 (10): 1178–83. PMID 12127568. doi:10.1016/S1357-2725(02)00064-X.
Benaim G, Villalobo A. . Eur. J. Biochem. 2002, 269 (15): 3619–31. PMID 12153558. doi:10.1046/j.1432-1033.2002.03038.x.
Leu TH, Maa MC. . Front. Biosci. 2004, 8 (1-3): s28–38. PMID 12456372. doi:10.2741/980.
Anderson NL, Anderson NG. . Mol. Cell Proteomics. 2003, 1 (11): 845–67. PMID 12488461. doi:10.1074/mcp.R200007-MCP200.
Kari C, Chan TO, Rocha de Quadros M, Rodeck U. . Cancer Res. 2003, 63 (1): 1–5. PMID 12517767.
Bonaccorsi L, Muratori M, Carloni V; 等. . Int. J. Androl. 2003, 26 (1): 21–5. PMID 12534934. doi:10.1046/j.1365-2605.2003.00375.x.
Reiter JL, Maihle NJ. . Annals of the New York Academy of Sciences. 2003, 995 (1): 39–47. PMID 12814937. doi:10.1111/j.1749-6632.2003.tb03208.x.
Adams TE, McKern NM, Ward CW. . Growth Factors. 2005, 22 (2): 89–95. PMID 15253384. doi:10.1080/08977190410001700998.
Ferguson KM. . Biochem. Soc. Trans. 2005, 32 (Pt 5): 742–5. PMID 15494003. doi:10.1042/BST0320742.
Chao C, Hellmich MR. . Growth Factors. 2005, 22 (4): 261–8. PMID 15621729. doi:10.1080/08977190412331286900.
Carlsson J, Ren ZP, Wester K; 等. . J. Neurooncol. 2006, 77 (1): 33–45. PMID 16200342. doi:10.1007/s11060-005-7410-z.
Scartozzi M, Pierantoni C, Berardi R; 等. . Anal. Quant. Cytol. Histol. 2006, 28 (2): 61–8. PMID 16637508.
Prudkin L, Wistuba II. . Annals of diagnostic pathology. 2006, 10 (5): 306–15. PMID 16979526. doi:10.1016/j.anndiagpath.2006.06.011.
Ahmed SM, Salgia R. . Respirology. 2007, 11 (6): 687–92. PMID 17052295. doi:10.1111/j.1440-1843.2006.00887.x.
Zhang X, Chang A. . J. Med. Genet. 2007, 44 (3): 166–72. PMC 2598028. PMID 17158592. doi:10.1136/jmg.2006.046102.
Cohenuram M, Saif MW. . JOP. 2007, 8 (1): 4–15. PMID 17228128.
Mellinghoff IK, Cloughesy TF, Mischel PS. . Clin. Cancer Res. 2007, 13 (2 Pt 1): 378–81. PMID 17255257. doi:10.1158/1078-0432.CCR-06-1992.
Nakamura JL. . Expert Opin. Ther. Targets. 2007, 11 (4): 463–72. PMID 17373877. doi:10.1517/14728222.11.4.463.

外部链接

MeSH（醫學主題詞）上面的Epidermal Growth Factor Receptor（美式英语）

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Kathryn M. Ferguson, Mitchell B. Berger, Jeannine M. Mendrola, Hyun Soo Cho, Daniel J. Leahy, Mark A. Lemmon. . Molecular Cell. 2003-02, 11 (2): 507–517 [2019-05-26]. ISSN 1097-2765. PMID 12620237.

[pmid15142631-2] Herbst RS. . Int. J. Radiat. Oncol. Biol. Phys. 2004, 59 (2 Suppl): 21–6. PMID 15142631. doi:10.1016/j.ijrobp.2003.11.041.

[pmid17671639-3] Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI. . J. Clin. Invest. August 2007, 117 (8): 2051–8. PMC 1934579. PMID 17671639. doi:10.1172/JCI32278.

[4] Yuhong Lu , Yanfeng Liu , Sebastian Oeck , Gary J. Zhang , Alexander Schramm , and Peter M. Glazer. . Cancer Res. November 1 2020, 80 (21): 4655-4667. doi:10.1158/0008-5472.CAN-20-1192. 请检查|date=中的日期值 (帮助)

[5] A.A. Armour, C.L. Watkins. . Cancer Res. October 1 2020, 80 (19): 4023-4024. doi:10.1158/0008-5472.CAN-20-0141. 请检查|date=中的日期值 (帮助)